Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI

NCT03840135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Infection

Interventions

DRUG: Polyoxidonium 6 mg/ml
OTHER: Placebo

Sponsor

NPO Petrovax